BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
Jun 03, 2013
 |  BioCentury  |  Analyst Picks & Changes

Analyst picks & changes

Analyst picks & changes

Company Bank Analyst Coverage Opinion Wk chg 5/31 cls
Aegerion Pharmaceuticals Inc. (NASDAQ:AEGR) Canaccord Salveen Richter Price target Buy 21% $72.83
JPMorgan Cory Kasimov Price target Overweight
Richter raised her target to $90 from $54 based on a physician tracking survey assessing the launch of Juxtapid lomitapide for homozygous familial hypercholesterolemia (hoFH). Of 213 patients...

Read the full 503 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury

Article Purchase

$150 USD
More Info >